Zsolt Pál Harsányi
Chairman bei EMERGENT BIOSOLUTIONS INC.
Vermögen: 182 810 $ am 31.03.2024
Profil
Zsolt Pál Harsányi is the founder of DynPort Vaccine Co. LLC, which was founded in 1996.
He is currently the Chairman at Exponential Biotherapies, Inc. since 2016, Chairman at Emergent BioSolutions, Inc. since 2004, Independent Director at Aptevo Therapeutics, Inc. since 2016, and Director at OptiFilter Research Zrt.
Dr. Harsányi's former positions include Chairman & Chief Executive Officer at Exponential Biotherapies, Inc. from 2004 to 2011, Chairman at N-Gene Research Laboratories, Inc., President at Porton International Plc (GREATER LONDON) from 1983 to 2004, and Vice President-Corporate Finance at E.F.
Hutton & Co., Inc. Dr. Harsányi's education includes an undergraduate degree from Amherst College in 1965 and a doctorate from Albert Einstein College of Medicine, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.05.2023 | 71 899 ( 0,14% ) | 181 904 $ | 31.03.2024 | |
APTEVO THERAPEUTICS INC
0,03% | 01.03.2024 | 193 ( 0,03% ) | 905 $ | 31.03.2024 |
Aktive Positionen von Zsolt Pál Harsányi
| Unternehmen | Position | Beginn |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Chairman | 01.04.2022 |
| APTEVO THERAPEUTICS INC. | Director/Board Member | 01.08.2016 |
Exponential Biotherapies, Inc.
 Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY. | Chairman | 01.01.2016 |
OptiFilter Research Zrt.
 OptiFilter Research Zrt. Industrial ConglomeratesProducer Manufacturing OptiFilter Research Zrt. manufactures cigarette filters. The firm offers diagnostic examination for cancer screening, human papillomavirus test and an epigenetic biomarker, and laboratory analysis. The company was founded on November 26, 2014 and is headquartered in Pécs, Hungary. | Director/Board Member | - |
Ehemalige bekannte Positionen von Zsolt Pál Harsányi
| Unternehmen | Position | Ende |
|---|---|---|
Exponential Biotherapies, Inc.
Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY. | Chief Executive Officer | 01.02.2011 |
| Porton International Plc (GREATER LONDON) | President | 01.12.2004 |
E.F. Hutton & Co., Inc.
 E.F. Hutton & Co., Inc. Financial ConglomeratesFinance Part of Barclays PLC, E.F. Hutton & Co., Inc. is a private company that provides investment and financial services. The company is based in Providence, RI. | Director of Finance/CFO | - |
DynPort Vaccine Co. LLC
 DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services DynPort Vaccine Co. LLC develops vaccines, biologic products and small molecule anti-infectives. It provides its products and services to the defense and military sectors in the United States. The company was founded in 1997 by Zsolt Pál Harsányi and is headquartered in Reston, VA. | Founder | - |
N-Gene Research Laboratories, Inc.
 N-Gene Research Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services N-Gene Research Laboratories, Inc. operates as a clinical stage biopharmaceutical firm which focuses on developing a series of synthetic small molecules having a therapeutic effect via stress response modulation. Its products include oral anti-diabetic, skincare, and prokynetic. The company was founded by Peter Literati-Nagy in 1997 and is headquartered in New York, NY. | Chairman | - |
Ausbildung von Zsolt Pál Harsányi
| Amherst College | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| APTEVO THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Exponential Biotherapies, Inc.
Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY. | Health Technology |
N-Gene Research Laboratories, Inc.
N-Gene Research Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services N-Gene Research Laboratories, Inc. operates as a clinical stage biopharmaceutical firm which focuses on developing a series of synthetic small molecules having a therapeutic effect via stress response modulation. Its products include oral anti-diabetic, skincare, and prokynetic. The company was founded by Peter Literati-Nagy in 1997 and is headquartered in New York, NY. | Commercial Services |
| Porton International Plc (GREATER LONDON) | Health Technology |
DynPort Vaccine Co. LLC
DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services DynPort Vaccine Co. LLC develops vaccines, biologic products and small molecule anti-infectives. It provides its products and services to the defense and military sectors in the United States. The company was founded in 1997 by Zsolt Pál Harsányi and is headquartered in Reston, VA. | Commercial Services |
E.F. Hutton & Co., Inc.
E.F. Hutton & Co., Inc. Financial ConglomeratesFinance Part of Barclays PLC, E.F. Hutton & Co., Inc. is a private company that provides investment and financial services. The company is based in Providence, RI. | Finance |
OptiFilter Research Zrt.
OptiFilter Research Zrt. Industrial ConglomeratesProducer Manufacturing OptiFilter Research Zrt. manufactures cigarette filters. The firm offers diagnostic examination for cancer screening, human papillomavirus test and an epigenetic biomarker, and laboratory analysis. The company was founded on November 26, 2014 and is headquartered in Pécs, Hungary. | Producer Manufacturing |
